• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

费城染色体阳性慢性髓性白血病的基因组多样性

Genomic diversity of Philadelphia-positive chronic myelogenous leukemia.

作者信息

Verma R S, Macera M J

机构信息

Division of Genetics, Long Island College Hospital, Brooklyn, NY 11201.

出版信息

Leuk Res. 1987;11(9):833-42. doi: 10.1016/0145-2126(87)90068-3.

DOI:10.1016/0145-2126(87)90068-3
PMID:3312828
Abstract

The incidence of breakpoints in CML patients with variant translocations was investigated. There was no relationship between the length of various chromosomes with breakpoint frequency. However, a significantly higher (p less than 0.05) incidence of breaks were seen on the long arms as compared to the short arms due mainly to the involvement of 9q and 22q in these translocations. Chromosome 17 showed a significantly (p less than 0.005) higher involvement in these translocations, however only when 9q34-qter was not cytogenetically involved. A total of 683 breaks were found in 225 cases. 362 of these were located at c-abl and c-sis, while 110 were at other oncogenetic sites. The prognostic and hematologic features of patients with variant translocations are not significantly different from those of CML cases with the typical 9q;22q translocation. Some of these complex translocation, where the breakpoints are correlated with oncogenetic sites, are further discussed in molecular terms.

摘要

对具有变异易位的慢性粒细胞白血病(CML)患者的断点发生率进行了研究。各种染色体的长度与断点频率之间没有关系。然而,与短臂相比,长臂上的断点发生率显著更高(p<0.05),这主要是由于这些易位中9号染色体长臂(9q)和22号染色体长臂(22q)的参与。17号染色体在这些易位中的参与率显著更高(p<0.005),但仅在细胞遗传学上9q34-qter未受累时如此。在225例病例中总共发现了683个断点。其中362个位于c-abl和c-sis,而110个位于其他致癌基因位点。具有变异易位的患者的预后和血液学特征与具有典型9q;22q易位的CML病例没有显著差异。其中一些复杂易位,其断点与致癌基因位点相关,将在分子层面进一步讨论。

相似文献

1
Genomic diversity of Philadelphia-positive chronic myelogenous leukemia.费城染色体阳性慢性髓性白血病的基因组多样性
Leuk Res. 1987;11(9):833-42. doi: 10.1016/0145-2126(87)90068-3.
2
Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
Cancer Genet Cytogenet. 1989 Mar;38(1):61-74. doi: 10.1016/0165-4608(89)90166-0.
3
Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis.
Blood. 1988 Mar;71(3):697-702.
4
Frequent and extensive deletion during the 9,22 translocation in CML.慢性粒细胞白血病9号与22号染色体易位过程中频繁且广泛的缺失。
Blood. 1986 Nov;68(5):1123-8.
5
Breakpoint distribution in variant Philadelphia translocations in chronic myeloid leukemia.慢性髓性白血病中变异型费城染色体易位的断点分布
Cancer Genet Cytogenet. 1986 Oct;23(2):167-70. doi: 10.1016/0165-4608(86)90414-0.
6
Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.通过原位杂交对人c-sis癌基因在Ph1阳性和Ph1阴性慢性粒细胞白血病中的定位。
Blood. 1984 Jan;63(1):223-5.
7
Molecular analysis of both translocation products of a Philadelphia-positive CML patient.一位费城染色体阳性慢性粒细胞白血病患者两种易位产物的分子分析。
Nucleic Acids Res. 1986 Sep 11;14(17):7071-82. doi: 10.1093/nar/14.17.7071.
8
Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.abl癌基因的激活及其在人类白血病染色体易位中的作用。
Mutat Res. 1988 May;195(3):231-43. doi: 10.1016/0165-1110(88)90002-4.
9
Involvement of chromosomal region 9q34 in a case of variant Ph1 translocation t(22;22).9q34染色体区域在一例变异型Ph1易位t(22;22)病例中的受累情况。
Leuk Res. 1986;10(9):1131-7. doi: 10.1016/0145-2126(86)90058-5.
10
Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.费城染色体阳性慢性髓性白血病(CML)中9号和22号染色体的断点。CML急变期重排的c-abl癌基因的扩增。
J Clin Invest. 1986 Nov;78(5):1392-6. doi: 10.1172/JCI112726.

引用本文的文献

1
[The molecular-cytogenetic characterization and tyrosine kinase inhibitors efficacy in newly diagnosed chronic phase CML patients with variant Philadelphia chromosomes].[初诊慢性期变异型费城染色体慢性髓性白血病患者的分子细胞遗传学特征及酪氨酸激酶抑制剂疗效]
Zhonghua Xue Ye Xue Za Zhi. 2018 Mar 14;39(3):212-218. doi: 10.3760/cma.j.issn.0253-2727.2018.03.008.
2
Clonal expansion after bone marrow transplantation in a patient with chronic myelogenous leukemia.
Blut. 1988 Nov;57(5):303-6. doi: 10.1007/BF00320358.
3
Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia.
Hum Genet. 1990 Oct;85(6):565-8. doi: 10.1007/BF00193575.